Effect and safety of endoscopic treatment for acute mild and moderate cholangitis associated with common bile duct stones, a multicenter feasibility study.

Effect and safety of endoscopic treatment for acute mild and moderate cholangitis associated with common bile duct stones, a multicenter feasibility study. - Effect and safety of endoscopic treatment for acute mild and moderate cholangitis associated with common bile duct stones, a multicenter feasibility study.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000008494

Enrollment

Registered

2012-08-06

Start date

2012-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute mild and moderate cholangitis associated with common biliary stones.

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Mild and moderate acute cholangitis associated with common biliary stones in Tokyo Guideline. 2) Excluded bile duct stricture by US, EUS, CT or MRCP. 3) Intact papilla of vater. 4) A value of more than 3 in performance status according to the scale of the Eastern Cooperative Oncology Group. 5) Patients aged 20 years and older. 6) Patients with informed consent for joining the presesnt study

Exclusion criteria

Exclusion criteria: 1) Sever acute cholangitis in Tokyo Guideline. 2) Malignant disease and biliary stricter by US, EUS, CT or MRCP. 3) Plt<50000, PT-INR>2.0 4) Acute pancreatitis 5) Ampullary neoplasm 6) Infiltration of the papillary area by pancreatic cancer 7) Billoth II gastrectomy, Roux-en-Y reconstruction 8) Anomalous pancreaticobiliary channel 9) Separate papillary orifices of the common bilie duct and pancreatic duct. 10) Choledochoduodenal Fisutula 11) A value of more than I-1 ipaired consiousness accoding to the scale of the Japan Coma Scale. 12) Severe heart disease 13) Severe pulmonary disease 14) Pregnant or lactating 15) Judged inappropriate by a doctor

Design outcomes

Primary

Measure	Time frame
Number of days until improvement	—

Secondary

Measure	Time frame
Complication rates	—

Countries

Japan

Contacts

Public ContactMidori Nishioka

Hokkaido University Hospital Clinical trial center

midorin@med.hokudai.ac.jp011-716-1161

Outcome results